Ciprofloxacin-induced persister-cells in Campylobacter jejuni

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Ciprofloxacin-induced persister-cells in Campylobacter jejuni. / Ovsepian, Armen; Larsen, Marianne Halberg; Vegge, Christina Skovgaard; Ingmer, Hanne.

I: Microbiology, Bind 166, Nr. 9, 2020, s. 849–853.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Ovsepian, A, Larsen, MH, Vegge, CS & Ingmer, H 2020, 'Ciprofloxacin-induced persister-cells in Campylobacter jejuni', Microbiology, bind 166, nr. 9, s. 849–853. https://doi.org/10.1099/mic.0.000953

APA

Ovsepian, A., Larsen, M. H., Vegge, C. S., & Ingmer, H. (2020). Ciprofloxacin-induced persister-cells in Campylobacter jejuni. Microbiology, 166(9), 849–853. https://doi.org/10.1099/mic.0.000953

Vancouver

Ovsepian A, Larsen MH, Vegge CS, Ingmer H. Ciprofloxacin-induced persister-cells in Campylobacter jejuni. Microbiology. 2020;166(9):849–853. https://doi.org/10.1099/mic.0.000953

Author

Ovsepian, Armen ; Larsen, Marianne Halberg ; Vegge, Christina Skovgaard ; Ingmer, Hanne. / Ciprofloxacin-induced persister-cells in Campylobacter jejuni. I: Microbiology. 2020 ; Bind 166, Nr. 9. s. 849–853.

Bibtex

@article{5092429cd07b4cd8bac7c0737107edf2,
title = "Ciprofloxacin-induced persister-cells in Campylobacter jejuni",
abstract = "Campylobacter jejuni is a major bacterial foodborne-pathogen. Ciprofloxacin is an important antibiotic for the treatment of C. jejuni, albeit high rates of fluoroquinolone resistance have limited its usefulness. Persister-cells are transiently antibiotic-tolerant fractions of bacterial populations and their occurrence has been associated with recalcitrant and persistent bacterial infections. Here, time-kill assays with ciprofloxacin (200×MIC, 25 µg ml-1) were performed in C. jejuni strains 81-176 and RM1221 and persister-cells were found. The frequency of survivors after 8 h of ciprofloxacin exposure was approx. 10-3 for both strains, while after 22 h the frequency was between 10-5-10-7, depending on the strain and growth-phase. Interestingly, the stationary-phase cultures did not display more persister-cells compared to exponential-phase cultures, in contrast to what has been observed in other bacterial species. Persister-cells after ampicillin exposure (100×MIC, 200 µg ml-1) were not detected, implying that persister-cell formation in C. jejuni is antibiotic-specific. In attempts to identify the mechanism of ciprofloxacin persister-cell formation, stringent or SOS responses were not found to play major roles. Overall, this study reports ciprofloxacin persister-cells in C. jejuni and challenges the notion of persister-cells as plainly dormant non-growing cells.",
author = "Armen Ovsepian and Larsen, {Marianne Halberg} and Vegge, {Christina Skovgaard} and Hanne Ingmer",
year = "2020",
doi = "10.1099/mic.0.000953",
language = "English",
volume = "166",
pages = "849–853",
journal = "Microbiology",
issn = "1350-0872",
publisher = "Society for General Microbiology",
number = "9",

}

RIS

TY - JOUR

T1 - Ciprofloxacin-induced persister-cells in Campylobacter jejuni

AU - Ovsepian, Armen

AU - Larsen, Marianne Halberg

AU - Vegge, Christina Skovgaard

AU - Ingmer, Hanne

PY - 2020

Y1 - 2020

N2 - Campylobacter jejuni is a major bacterial foodborne-pathogen. Ciprofloxacin is an important antibiotic for the treatment of C. jejuni, albeit high rates of fluoroquinolone resistance have limited its usefulness. Persister-cells are transiently antibiotic-tolerant fractions of bacterial populations and their occurrence has been associated with recalcitrant and persistent bacterial infections. Here, time-kill assays with ciprofloxacin (200×MIC, 25 µg ml-1) were performed in C. jejuni strains 81-176 and RM1221 and persister-cells were found. The frequency of survivors after 8 h of ciprofloxacin exposure was approx. 10-3 for both strains, while after 22 h the frequency was between 10-5-10-7, depending on the strain and growth-phase. Interestingly, the stationary-phase cultures did not display more persister-cells compared to exponential-phase cultures, in contrast to what has been observed in other bacterial species. Persister-cells after ampicillin exposure (100×MIC, 200 µg ml-1) were not detected, implying that persister-cell formation in C. jejuni is antibiotic-specific. In attempts to identify the mechanism of ciprofloxacin persister-cell formation, stringent or SOS responses were not found to play major roles. Overall, this study reports ciprofloxacin persister-cells in C. jejuni and challenges the notion of persister-cells as plainly dormant non-growing cells.

AB - Campylobacter jejuni is a major bacterial foodborne-pathogen. Ciprofloxacin is an important antibiotic for the treatment of C. jejuni, albeit high rates of fluoroquinolone resistance have limited its usefulness. Persister-cells are transiently antibiotic-tolerant fractions of bacterial populations and their occurrence has been associated with recalcitrant and persistent bacterial infections. Here, time-kill assays with ciprofloxacin (200×MIC, 25 µg ml-1) were performed in C. jejuni strains 81-176 and RM1221 and persister-cells were found. The frequency of survivors after 8 h of ciprofloxacin exposure was approx. 10-3 for both strains, while after 22 h the frequency was between 10-5-10-7, depending on the strain and growth-phase. Interestingly, the stationary-phase cultures did not display more persister-cells compared to exponential-phase cultures, in contrast to what has been observed in other bacterial species. Persister-cells after ampicillin exposure (100×MIC, 200 µg ml-1) were not detected, implying that persister-cell formation in C. jejuni is antibiotic-specific. In attempts to identify the mechanism of ciprofloxacin persister-cell formation, stringent or SOS responses were not found to play major roles. Overall, this study reports ciprofloxacin persister-cells in C. jejuni and challenges the notion of persister-cells as plainly dormant non-growing cells.

U2 - 10.1099/mic.0.000953

DO - 10.1099/mic.0.000953

M3 - Journal article

C2 - 32697188

VL - 166

SP - 849

EP - 853

JO - Microbiology

JF - Microbiology

SN - 1350-0872

IS - 9

ER -

ID: 247339785